This article is more than 5 years old. Information may no longer be current.

Iridex, Quantel resolve infringement dispute

Issue: February 2019

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Iridex and Quantel have resolved a patent and trademark infringement dispute, with each dismissing a lawsuit against the other.

According to an Iridex press release, the company dismissed its lawsuit, filed in January 2018, that alleged Quantel not only infringed the company’s U.S. Patent No. 7,771,417 and MicroPulse trademark, but also breached an earlier agreement between the two parties.

In Europe, Quantel withdrew its opposition to Iridex’s patent No. 1856774.

“We place a high priority defending our intellectual property, and I am very pleased with the swift resolution of the U.S. lawsuit and the intellectual property claims in Europe. Our MicroPulse technology and its brand recognition now remain protected from competitive misuse and misrepresentation,” William Moore, Iridex president and CEO, said in the release.